Stock Track | Celestica Stock Soars 5.25% Pre-Market as Q3 Earnings Release Looms

Stock Track
Oct 27, 2025

Shares of Celestica Inc. (NYSE:CLS) surged 5.25% in pre-market trading on Monday, as investors eagerly await the company's third-quarter earnings report scheduled for release after the closing bell. The Toronto, Canada-based electronics manufacturing services company has captured market attention with analysts projecting strong financial results.

Wall Street analysts are expecting Celestica to report quarterly earnings of $1.49 per share, a significant increase from $1.04 per share in the same quarter last year. The consensus estimate for the company's quarterly revenue stands at $3.04 billion, up from $2.5 billion in the year-ago period. These optimistic projections, coupled with recent analyst upgrades, appear to be fueling the stock's pre-market rally.

Several top analysts have recently revised their outlook on Celestica. RBC Capital's Paul Treiber maintained an Outperform rating and raised the price target from $225 to $315, while Goldman Sachs initiated coverage with a Buy rating and a $340 price target. The company's strong performance in the previous quarter, where it reported better-than-expected Q2 results and raised its FY25 guidance, has also contributed to the positive sentiment. As Celestica prepares to unveil its Q3 results, investors seem to be positioning themselves for potentially another round of impressive financials.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10